Showing 1 – 20 of 55
Relevance | Newest | Oldest |
  • National Library of Medicine May Receive Funding Boost

    Abstract Full Text
    JAMA. 2016; 316(14):1439-1439. doi: 10.1001/jama.2016.14564
  • Database on Elder Health Broadens

    Abstract Full Text
    JAMA. 2014; 311(16):1603-1603. doi: 10.1001/jama.2014.4501
  • Database Allows Researchers, Patients to Scrutinize Supplements

    Abstract Full Text
    JAMA. 2013; 310(4):361-361. doi: 10.1001/jama.2013.8795
  • The Restructuring of Structured Abstracts: Adding a Table in the Results Section

    Abstract Full Text
    JAMA. 2013; 309(5):491-492. doi: 10.1001/jama.2013.76
  • JAMA December 28, 2011

    Figure 1: Relationship Between CYP2C19 Genotype, Active Drug Metabolite, and Platelet Reactivity

    A, The expected mean active clopidogrel metabolite concentration in a white population for all individuals treated with 75 mg and for individuals with loss-of-function and normal/increased-function CYP2C19 alleles.a indicates mean active clopidogrel metabolite concentration regardless of genotype, area under the plasma concentration-time curve from the time of administration to the last measurable concentration (AUC0-t) = 0.35 μM × hr;b indicates difference in clopidogrel active metabolite concentration between *2 through *8 and *1 or *17, AUC0-t = 0.14 μM × hr. The central tendency and measure of dispersion are obtained from Mega et al: CYP2C19 *1 or *17 summary estimates were pooled from ultra and extensive metabolizer groups and *2 through*8 from intermediate and poor metabolizer groups. The heights of the plots are proportional to the allele frequency of *2 (the most common loss-of-function * allele; rs4244285 mean allele frequency = 0.13; European ancestry [NCBI Single Nucleotide Polymorphism database, http://www.ncbi.nlm.nih.gov/projects/SNP]); ie, as *1 is more common (87%) than *2 (13%), the height of the plot for the *1 or *17 group is higher than that for *2, reflecting the number within the population that will harbor this genotype. B, Meta-analysis of 4 treatment-only studies (4341 individuals) reporting CYP2C19 genotype and platelet reactivity after 600 mg of clopidogrel (using various assays). Error bars indicate 95% CIs.
  • JAMA November 9, 2011

    Figure: Flow Diagram of Selection of Systematic Reviews and Primary Results of Analysis

    NLM indicates National Library of Medicine.
  • JAMA June 1, 2011

    Figure: The National Library of Medicine

  • JAMA June 1, 2011

    Figure: The National Library of Medicine

    The Visible Human, a digital image library of the complete anatomy of 2 individuals who each willed their body to science, has wide-ranging applications in medical education, treatment planning, industry, and other areas.
  • JAMA June 1, 2011

    Figure: The National Library of Medicine

    ClinicalTrials.gov, a registry of clinical trials launched by the National Library of Medicine, is the world's largest clinical trials registry and the only such database to include summaries of trial results.
  • The National Library of Medicine

    Abstract Full Text
    JAMA. 2011; 305(21):2158-2161. doi: 10.1001/jama.2011.703
  • Issues in the Registration of Clinical Trials

    Abstract Full Text
    JAMA. 2007; 297(19):2112-2120. doi: 10.1001/jama.297.19.2112
  • JAMA January 24, 2007

    Figure: Varmus Papers

    The National Library of Medicine has released an extensive collection of papers of Nobel laureate Harold Varmus, MD, on its Web site.
  • Varmus Papers

    Abstract Full Text
    JAMA. 2007; 297(4):354-354. doi: 10.1001/jama.297.4.354-b
  • Medical Books From the Cradle Delight in a Digital Age

    Abstract Full Text
    JAMA. 2004; 292(20):2455-2456. doi: 10.1001/jama.292.20.2455
  • Clinical Trial Registration: A Statement From the International Committee of Medical Journal Editors

    Abstract Full Text
    JAMA. 2004; 292(11):1363-1364. doi: 10.1001/jama.292.11.1363
  • JAMA July 16, 2003

    Figure: FDA to Speed Generics

    This illustration of the human midbrain, by artist Bill Andrews, was inspired by the drawings of da Vinci. It and other works are on display at the National Library of Medicine.(Artist: Bill Andrews)
  • Pauling Papers On-line

    Abstract Full Text
    JAMA. 2003; 289(11):1368-1368. doi: 10.1001/jama.289.11.1368-a
  • JAMA March 12, 2003

    Figure: Medicine on the Lewis and Clark Trail

    Bloodletting (shown here in this 1804 print) was a common medical practice during the early 19th century, and was employed by Lewis during the expedition. (Credit: National Library of Medicine)
  • JAMA March 12, 2003

    Figure: Medicine on the Lewis and Clark Trail

  • JAMA March 12, 2003

    Figure: Medicine on the Lewis and Clark Trail

    The frontispiece of expedition member Patrick Gass' Journal of the Voyages and Travels of A Corps of Discovery, published in 1810, shows a potential, rather than actual, danger of the journey. Members of the expedition endured snakebites, frostbite, malaria, dysentery, syphilis, gonorrhea, bear attacks, and other hazards. (Credit: Courtesy of the University of Pennsylvania, Philadelphia)